Abstract:Stress response and depression have a crucial impact on modern society. Although the symptoms are well characterized, the molecular mechanisms underlying depression are largely unknown. Currently, the monoaminergic systems, especially serotonergic systems, have received the most attention in the research of depression. Accumulating evidence suggests that the glutamatergic and GABAergic system play an important role in the neurobiology and treatment of this disease. Multiple studies have shown that serotonin (5-HT) could modulate the neurotransmission of glutamic acid (Glu) and gamma-aminobutyric acid (GABA). The orbitofrontal cortex (OFC), which is involved in the pathophysiology and treatment of depression, plays a critical role in the control of higher brain functions and it mainly receives a dense 5-HT innervation from the dorsal raphe nucleus. There exist some 5-HT1A receptors on glutamatergic neurons and GABAergic neurons in the OFC. The purpose of this research was to elucidate the modulatory action of 5-HT1A receptor on the functions of Glu and GABA, which are the principal neurotransmitters mediating excitatory and inhibitory signals in the OFC respectively, in a well-established animal model of depression induced by chronic unpredictable mild stress (CUMS). We used CUMS in rat to mimic the core symptoms in human. Using the pharmacology approaches by microinjecting of 5-HT1A receptor agonist 8-OH-DPAT and its antagonist WAY100635 to the OFC, we detected behavioral changes by using behavior tests including sucrose preference test, open field test and tail suspension test. In addition, high-performance liquid chromatography (HPLC) was used to detect the level of neurotransmitters such as 5-HT, Glu and GABA in the OFC, respectively. CUMS group showed a variety of behavioral characteristics of depression, including a significant reduction in the sucrose preference, and locomotion, rearing and grooming in the open field test, and a significant increase in immobility time in the tail suspension test compared with control group. In addition, CUMS group showed that a significant increase in the concentration of Glu, but no significant difference in the levels of 5-HT and GABA in the OFC. Depression-like behaviors of CUMS rats were obviously ameliorated after being treated with 8-OH-DPAT, while the concentration of Glu was decreased. Rats received WAY100635 in control group showed similar depression-like behaviors and similar increased Glu levels. However, 5-HT level and GABA concentration were not altered in both groups received 8-OH-DPAT or WAY100635. These findings indicated that the mechanism through which CUMS could induce depression-like behaviors, probably is not due to the decrease of 5-HT level within the OFC, but because of excessive release of Glu that resulted from that 5-HT could not regulate glutamatergic neurons or the decrease of 5-HT1A receptor function on glutamatergic neurons within the OFC during stress. Our data suggested that 5-HT1A receptor in the OFC plays an important role in modulating the synthesis and release of Glu during CUMS. This study provided insights on modulation of glutamate transmission in depression.

Elevated Dopamine D2 Receptor in Prefrontal Cortex of CUMS Rats is Associated with Downregulated Camp-Independent Signaling Pathway

Metabolomics Analysis of the Prefrontal Cortex in a Rat Chronic Unpredictable Mild Stress Model of Depression

Downregulation of CRTC1 is Involved in CUMS-Induced Depression-Like Behavior in the Hippocampus and Its RNA Sequencing Analysis

CUMS induces depressive-like behaviors and cognition impairment by activating the ERS-NLRP3 signaling pathway in mice

Orbitofrontal Cortex 5-HT1A Receptor Modulate Glutamate and GABA in Depression Induced by Chronic Unpredictable Mild Stress

[Activation of Hippocampal D1 Dopamine Receptor Inhibits Glutamate-Mediated Depression Induced by Chronic Unpredictable Mild Stress in Rats].

Alteration in NMDAR subunits in different brain regions of chronic unpredictable mild stress (CUMS) rat model

Metabolic Profiling Reveals Disorder Of Amino Acid Metabolism In Four Brain Regions From A Rat Model Of Chronic Unpredictable Mild Stress

Rasd2 regulates depression-like behaviors via DRD2 neurons in the prelimbic cortex afferent to nucleus accumbens core circuit

Effects of stress of different duration on depression-like behavior and expression of CB1 and GluA1 in medial prefrontal cortex of rats

Analysis of Expression of Brain-Derived Neurotrophic Factor in Rats with Chronic Unpredictable Mild Stress

Hippocampal mRNA expression profiling in mice exposed to chronic unpredictable mild stress

Imbalance of Leptin Pathway and Hypothalamus Synaptic Plasticity Markers Are Associated with Stress-Induced Depression in Rats

Differential Regulation of DNA Methylation at the CRMP2 Promoter Region Between the Hippocampus and Prefrontal Cortex in a CUMS Depression Model

CRTC1 signaling involvement in depression-like behavior of prenatally stressed offspring rat

Resveratrol Exerts Antidepressant Properties in the Chronic Unpredictable Mild Stress Model Through the Regulation of Oxidative Stress and Mtor Pathway in the Rat Hippocampus and Prefrontal Cortex.

Involvement of Hippocampal Serotonin and Neuropeptide Y in Depression Induced by Chronic Unpredicted Mild Stress

Cyclooxygenase-2 Signalling Pathway in the Cortex is Involved in the Pathophysiological Mechanisms in the Rat Model of Depression

Involvement of Chronic Unpredictable Mild Stress-Induced Hippocampal LRP1 Up-Regulation in Microtubule Instability and Depressive-Like Behavior in a Depressive-Like Adult Male Rat Model.

Dorsal raphe dopaminergic neurons target CaMKII+ neurons in dorsal bed nucleus of the stria terminalis for mediating depression-related behaviors

New insights into individual differences in response to chronic unpredictable mild stress (CUMS) in rats with respect to hippocampal BDNF and GSK3-β expression levels